CSIMarket
 
Neogenomics Inc   (NEO)
Other Ticker:  
 
    Sector  Technology    Industry IT Infrastructure
   Industry IT Infrastructure
   Sector  Technology
 

Neogenomics Inc's Customers Performance

NEO

 
NEO's Source of Revenues In the Q1, Neogenomics Inc 's corporate clients experienced a reduction by -6.57 % in their costs of revenue, compared to a year ago, sequentially costs of revenue were trimmed by -16.28 %. During the corresponding time, Neogenomics Inc recorded revenue increase by 13.3 % year on year, sequentially revenue fell by -0.46 %. While revenue at the Neogenomics Inc 's corporate clients recorded rose by 3.98 % year on year, sequentially revenue fell by -5.34 %.

List of NEO Customers




Customers of Neogenomics Inc saw their costs of revenue decrease by -6.57 % in Q1 compare to a year ago, sequentially costs of revenue were trimmed by -16.28 %, for the same period Neogenomics Inc recorded revenue increase by 13.3 % year on year, sequentially revnue fell by -0.46 %.

List of NEO Customers



   
Customers Net Income grew in Q1 by Customers Net margin grew to
44.29 % 3.89 %
Customers Net Income grew in Q1 by 44.29 %


Customers Net margin grew to 3.89 %



Neogenomics Inc's Customers, Q1 2024 Revenue Growth By Industry
Customers in Healthcare Facilities Industry      6.9 %
Customers in Pharmacy Services & Retail Drugstore Industry      3.7 %
     
• Customers Valuation • Customers Mgmt. Effect.


Neogenomics Inc's Comment on Sales, Marketing and Customers



Our direct sales force has been trained extensively in cancer genetic testing and consultative selling skills to service the needs of clients. Our sales team for the clinical cancer testing services is organized into five regions ? Northeast, Southeast, North Central, South Central, and West. Our Pharma Services segment has a dedicated team of business development specialists who are experienced in working with pharma sponsors and helping them with the testing needs of their research and development projects as well as Phase I, II and III studies. These sales representatives utilize our custom Customer Relationship Management System (?CRM?) to manage their territories, and we have integrated the key customer care functionality within our Laboratory Information Services (?LIS?) into the CRM so that our sales representatives can stay informed of emerging issues and opportunities within their regions. Our in-house customer care team is aligned with our field sales team to serve the needs of our clients by utilizing the same LIS and CRM. Our field teams can see in real-time when a client calls the laboratory, the reason for the call, the resolution, and if face-to-face interaction is needed for follow-up. Our sales force educates clients on new test offerings and their proper utilization and our representatives are often seen as trusted advisors by our clients.





Neogenomics Inc's Comment on Sales, Marketing and Customers


Our direct sales force has been trained extensively in cancer genetic testing and consultative selling skills to service the needs of clients. Our sales team for the clinical cancer testing services is organized into five regions ? Northeast, Southeast, North Central, South Central, and West. Our Pharma Services segment has a dedicated team of business development specialists who are experienced in working with pharma sponsors and helping them with the testing needs of their research and development projects as well as Phase I, II and III studies. These sales representatives utilize our custom Customer Relationship Management System (?CRM?) to manage their territories, and we have integrated the key customer care functionality within our Laboratory Information Services (?LIS?) into the CRM so that our sales representatives can stay informed of emerging issues and opportunities within their regions. Our in-house customer care team is aligned with our field sales team to serve the needs of our clients by utilizing the same LIS and CRM. Our field teams can see in real-time when a client calls the laboratory, the reason for the call, the resolution, and if face-to-face interaction is needed for follow-up. Our sales force educates clients on new test offerings and their proper utilization and our representatives are often seen as trusted advisors by our clients.








NEO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Neogenomics Inc 1,795.82 609.85 -84.23 2,000
Heartland Media Acquisition Corp 202.86 0.00 4.01 0
Tenet Healthcare Corp 13,191.42 20,895.00 3,349.00 108,000
Davita Inc 12,544.38 12,338.00 1,092.29 69,000
The Kroger Co 38,739.99 148,258.00 2,249.00 420,000
Fresenius Medical Care Ag 6,235.04 21,788.05 820.35 1,254
Cvs Health Corporation 70,369.18 360,935.00 7,350.00 300,000
Rite Aid Corp 35.86 23,475.49 -1,635.20 50,000
SUBTOTAL 141,318.72 587,689.54 13,229.45 948,254


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com